JK06

· Salubris Biotherapeutics Inc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JK06, covering 2026-03-05 to 2026-03-05. Get the full timeline:

Most recent: Clinical Trial Update: Study of JK06 in Patients With Unresectable Locally Advanced or Metastatic Cancer [Phase 1, Phase 2]